Physiopathology of diabetic neuropathies. Functional exploration of peripheral involvement;Physiopathologie des neuropathies diabetioues. Exploration fonctionnelle des atteintes peripheriques

Diabetes and Metabolism

Volumn 24, Issue SUPPL. 3, 1998, Pages 73-78

  Raccah, D ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Electromyography; Genetic factors; Metabolic factors; Neuropathy; Physiopathology; Vascular factors

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARNITINE; LINOLEIC ACID; NERVE GROWTH FACTOR; NITRIC OXIDE; OXYGEN RADICAL; POLYOL; PROSTAGLANDIN;

CONFERENCE PAPER; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; ELECTROMYOGRAPHY; FATTY ACID METABOLISM; GENETIC PREDISPOSITION; HEREDITY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PROTEIN GLYCOSYLATION; VASCULAR DISEASE; BIOSYNTHESIS; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; REVIEW; RISK FACTOR; VASODILATATION;

DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NITRIC OXIDE; PERIPHERAL NERVOUS SYSTEM; RISK FACTORS; VASODILATION;

EID: 0032197161     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Pirart J. Diabetes mellitus and its degenerative complications : a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care, 1978, 1, 168-188.
2. DCCT Research group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
3. Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med, 1987, 316, 599-606.
4. Greene LA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA. Complications : neuropathy, pathogenetic considerations. Diabetes Care, 1992, 15, 1902-1925.
5. Horrobin DF. Gamma linolenic acid. Rev. Contemporary Pharmaco-therapy, 1990, 1, 1-41.
6. The Gamma-linolenic acid multicenter trial group. Treatment of diabetic neuropathy with gamma-linolenic acid. Diabetes Care, 1990, 16, 8-15.
7. Subbiah MTR, Deitemeyer D. Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats. Biochem Med, 1980, 23, 231-235.
8. Shimizu K, Muramatsu M, Kakegawa Y, et al. Role of prostaglandin H2 as an endothelium-derived contracting factor in diabetic state. Diabetes, 1993, 42, 1246-1252.
9. Harrison HE, Reece AH, Johson M. Decreased vascular prostacyclin in experimental diabetes. Life Sci, 1978, 23, 354-356.
10. Fritz IB. Carnitine and its role in fatty acid metabolism. Adv Lipid Res, 1963, 1, 285-334.